ArticleFrontiers in neuroscience2025
Chemogenetic tools for modulation of spatial learning in dopamine transporter deficient rats.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: We used the chemogenetic tools for the activation of norepinephrine (NE) release in the prefrontal cortex (PFC) of dopamine transporter knockout (DAT-KO) rats. The objective of this study was to evaluate the effect of chemogenetic activation of NE release in the PFC on the performance of a spatial behavior task by DAT-KO rats. The rats DAT-KO rats with deletion of DAT gene were created as a valuable model for persistently elevated extracellular DA levels. The DAT-KO rats show marked behavioral abnormalities: impulsivity, stereotypy and reduced learning ability. Such hyperdopaminergia is thought to be one of the causes of disorders such as schizophrenia, mania and attention deficit hyperactivity disorder (ADHD). The Locus Coeruleus (LC) is a critical area in the brain that plays an important role in control of several physiological and behavioral processes due to the existence of extensive connections to cortical and subcortical structures. Its activity can modulate both norepinephrine and dopamine neurotransmission, particularly in the PFC. Materials and methods: We used canine adenovirus type 2 (CAV2) to selectively activate LC-NA neurons in DAT-KO rats. The chemogenetic modulation of spatial learning in knockout and wild-type (WT) rats was tested in the Hebb-Williams maze. Variables such as the distance traveled, time taken to reach the goal box, number of errors and the perseverative patterns of activity were analyzed. Results: Norepinephrine release from the LC to the PFC reduced hyperactive behavioral patterns in rats lacking the dopamine transporter (DAT-KO rats) with spontaneously elevated dopamine transmission. These manipulations in hyperdopaminergic mutants also caused amelioration of cognitive abnormalities in spatial learning task by decrease the perseverative activity and the number of visits to the error zones. Furthermore, chemogenetic activation of NE neurotransmission in these animals significantly improved their performance. Conclusion: The results obtained in this study highlight an important modulatory role of NE transmission from LC to PFC on hyperactivity and cognitive dysfunctions of hyperdopaminergic DAT-KO rats lacking the dopamine transporter.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.